← All trials
NCT04563325
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 15, 2020
- Primary completion
- Sep 15, 2023
- Completion date
- Sep 15, 2024
- First posted
- Sep 24, 2020
- Last posted
- Oct 5, 2020
- Enrollment
- 180
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of CopenhagenLead sponsor
- Innovation Fund DenmarkCollaborator
- University of CopenhagenReponsible party - principal investigator
- University of CopenhagenOverall official - principal investigator
- University of CopenhagenStudy chair
- Copenhagen Health Science PartnersCollaborator
- University of CopenhagenCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.